COVIDSurg-Cancer Urology Overview



COVIDSurg-Cancer Urology


Many thanks for your fantastic contribution to the COVIDSurg-Cancer project. COVIDSurg are collaborating with another collaborative group, British Urology Researchers in Surgical Training (BURST) with funding from The Urology Foundation to understand the longer term impact of COVID-19 on patients diagnosed with urological cancer and undergoing urological surgery during the pandemic.

We are now running a longer term follow up study of the patients with bladder, renal and prostate cancer. Follow up will be once a year for up to 3 years for renal and bladder cancer patients, and up to 1 year for prostate cancer patients starting in March 2021. The BURST team are working with the Birmingham Centre for Observational and Prospective Studies (BiCOPS), at the University of Birmingham to coordinate the study.

COVID-19 has presented unique challenges and areas of interest in the management and pathway of cancer patients. We now need your help to explore this unique patient group that may have had surgery delayed or an alternative treatment as a result of the COVID-19 pandemic, and the long-term implications.

Key Features

  1. You do not need to identify any new patients - we are only interested in patients that you captured during the 3-month COVIDSurg-Cancer identification window.
  2. We hope to follow-up the patient up to 3-years for renal and bladder cancer patients, and 1 year for prostate cancer patients from study entry.
  3. If you wish to take part, we would hope to collect data once per year for the duration of the study.
  4. The study will end in Summer 2023 for renal and bladder cancer patients after the final patient entered into the study reaches their 3-year endpoint. For prostate cancers the study will end in Summer 2021 after the final patient reaches their 1-year endpoint.

Click Here for Study Protocol

Your efforts in data collection will be recognised with PubMed-indexed collaborative authorship on resulting output.


Interested? Next steps:


Please confirm your participation by completing the REDCap survey link below. We’ll be in touch once you have completed this sign up form.

Click here for COVIDSurg-Cancer Urology Registration REDCap survey

Please ensure that you have kept a record locally of the identifiable Medical Record Numbers and linked REDCap IDs for all patients you entered into COVIDSurg-Cancer. This allows you or a colleague to look back at records and update results annually. You may wish to save this on a password protected hospital computer.

Review your ethical/audit/institutional review board approval with your hospital to ensure there is sufficient approvals to cover three-years for extended follow-up.

Please read through the study protocol attached above.

If you have any questions, please don't hesitate to contact us on urocovidsurg@contacts.bham.ac.uk.

Copyright British Urology Researchers in Surgical Training (BURST) Research Collaborative @ 2021. Join Us as a Sponsor